We are redefining drug development
Where Others Aren't
Eiger BioPharmaceuticals is focused on the development and commercialization of first-in-class targeted therapies for serious rare and ultra-rare diseases
We are committed to more rapidly delivering important medicines to patients with serious rare and ultra-rare diseases through developing first-in-class, well-characterized drugs acting on newly identified or novel targets
Whatever it takes
Eiger has discovered untapped therapeutic potential of molecules with well understood safety profiles with the goal of developing medications for life-threatening diseases that have no approved treatments.
There are no upcoming events scheduled at this time.